Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A synthetic small molecule with the chemical formula C18H16FN3, 4-(4-fluorophenyl)-1-cyclopropylmethyl-5-(4-pyridyl)-imidazole is an experimental compound primarily referenced in chemical and pharmacological databases. It features a substituted imidazole core with a cyclopropylmethyl group at position 1, a para-fluorophenyl group at position 4, and a pyridyl group at position 5. The compound is cataloged as an experimental drug and has not been approved for clinical use or assigned to any marketed pharmaceutical product. Its mechanism of action, biological targets, therapeutic indications, and clinical development status are not specified in available references[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 4-(4-fluorophenyl)-1-cyclopropylmethyl-5-(4-pyridyl)-imidazole.